by editor | Mar 14, 2017 | Blog, Pharmaceutical
The interview provides an outline for Nutra Pharma’s growth plans over the next eighteen months. March 14, 2017 — Coral Springs, Florida — Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company developing drugs for the treatment of Multiple...
by editor | Mar 14, 2017 | Biotech, Blog, Pharmaceutical
StockGuru Interview Rik Deitsch – Chairman and CEO of Nutra Pharma (OTCQB: NPHC) Mobile users may listen using THIS LINK About Rik Deitsch – from the Nutra Pharma website: StockGuru Interview: Rik Deitsch – Chairman and CEO of...
by GlobeNewsWire | Sep 6, 2016 | Blog, Globe Newswire, Pharmaceutical
BOTHELL, Wash., Sept. 06, 2016 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced the appointment of Elisabeth A. Sandoval as chief commercial...
by GlobeNewsWire | Sep 6, 2016 | Biotech, Globe Newswire, Pharmaceutical
DURHAM, N.C., Sept. 06, 2016 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H, Chief Executive Officer of Chimerix, will...
by GlobeNewsWire | Oct 5, 2015 | Featured, Globe Newswire, Health Stock, Pharmaceutical
SILVER SPRING, Md., Oct. 05, 2015 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Sep 9, 2015 | Client News, Feature Box, Featured, Globe Newswire, Health Stock, Medical, Medical Stocks, Pharmaceutical
Strong Efficacy Signal Established in Genetically Identified Subset of ADHD PatientsDevelopment will Include Neuropsychiatric Symptoms of 22q11.2 Deletion SyndromePHILADELPHIA, Sept. 9, 2015 (GLOBE NEWSWIRE) — Medgenics, Inc. (NYSE MKT:MDGN) today announced the...